Yanqiu Song MD, PhD Bailong Liu MD, PhD Meng Guan Master of Medicine Min Liu
10.1080/15384047.2018.1491502
Cancer Biol Ther
2018;19(12):1093-1096.
apatinib tki vegf vegfr2 intractable peritumoral brain edema radiotherapy
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/30081717/
Antineoplastic Agents / therapeutic use Brain Edema / drug therapy Brain Edema / etiology Brain Neoplasms / complications Protein Kinase Inhibitors / therapeutic use Pyridines / therapeutic use
Antineoplastic Agents / therapeutic use Brain Edema / drug therapy Brain Edema / etiology Brain Neoplasms / complications Protein Kinase Inhibitors / therapeutic use Pyridines / therapeutic use Case Reports Research Support, Non-U.S. Gov't Review Antineoplastic Agents / administration & dosage Antineoplastic Agents / adverse effects Biomarkers, Tumor Brain Edema / diagnosis Brain Neoplasms / diagnosis Brain Neoplasms / drug therapy Brain Neoplasms / radiotherapy Capillary Permeability Female Humans Immunohistochemistry Magnetic Resonance Imaging Middle Aged Protein Kinase Inhibitors / administration & dosage Protein Kinase Inhibitors / adverse effects Pyridines / administration & dosage Pyridines / adverse effects Radiotherapy / adverse effects Radiotherapy / methods Treatment Outcome Vascular Endothelial Growth Factor A / metabolism Antineoplastic Agents Biomarkers, Tumor Protein Kinase Inhibitors Pyridines VEGFA protein, human Vascular Endothelial Growth Factor A apatinib
PMC6301820
30081717
Successful treatment using apatinib in intractable brain edema: A case report and literatures review
2018